AMWL

American Well Corp

AMWL.US business.amwell.com + Research + Basket
CIK 0001393584
Employees 562
Phone 617 204 3500
Fiscal year end December
IPO Sep 17, 2020
Address 75 State Street, Boston, MA, United States, 02109
12.73
-2.25 (-15.02%)
USD · NYSE
52-week range
3.71
15.16
Trading at 79% of the 52-week range
Market Cap
254.79M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
13.07
Div. Yield
N/A
% Institutions
47.52%
% Insiders
4.57%

1 Year

+147.2%

3 Year

-45.6%

10 Year

-97.2%
Description

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Actions

Add an action for AMWL.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Dr. Ido Schoenberg M.D. Chairman & CEO 1965
Mr. Mark J. Hirschhorn CPA Executive VP, COO & CFO 1965
Mr. Dan Zamansky Chief Product & Technology Officer 1984
Mr. Paul Francis McNeice Vice President of Accounting 1977
Anna Nesterova Head of Legal & Deputy General Counsel NA
Mr. Michael Miller Senior Vice President & Chief Sales Officer NA
Ms. Phyllis I. Gotlib President of Amwell International 1958
Dr. Cynthia Horner FAAFP, M.D. Chief Medical Officer & President of Amwell Medical Group NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Apr 01, 2026 Paul Francis Mcneice N/A Sale 383.00 $5.30 $2.03K SEC
Apr 01, 2026 Phyllis Gotlib N/A Sale 3.71K $5.30 $19.64K SEC
Apr 01, 2026 Dmitry Zamansky N/A Sale 5.58K $5.30 $29.55K SEC
Jan 02, 2026 Dmitry Zamansky N/A Sale 6.24K $4.85 $30.28K SEC
Jan 02, 2026 Paul Francis Mcneice N/A Sale 384.00 $4.85 $1.86K SEC
Jan 02, 2026 Phyllis Gotlib N/A Sale 3.71K $4.85 $17.98K SEC
Dec 18, 2025 Deborah C Jackson N/A Sale 612.00 $4.71 $2.88K SEC
Dec 01, 2025 Paul Francis Mcneice N/A Sale 113.00 $4.06 $458.78 SEC
Dec 01, 2025 Phyllis Gotlib N/A Sale 3.57K $4.06 $14.51K SEC
Oct 01, 2025 Phyllis Gotlib N/A Sale 4.96K $6.11 $30.30K SEC
Oct 01, 2025 Paul Francis Mcneice N/A Sale 332.00 $6.11 $2.03K SEC
Sep 15, 2025 Deborah C Jackson N/A Sale 4.53K $6.56 $29.72K SEC
Sep 03, 2025 Dmitry Zamansky N/A Sale 25.61K $6.77 $173.35K SEC
Sep 02, 2025 Deborah C Jackson N/A Sale 4.53K $6.79 $30.77K SEC
Sep 02, 2025 Paul Francis Mcneice N/A Sale 113.00 $6.78 $766.14 SEC
Sep 02, 2025 Phyllis Gotlib N/A Sale 4.78K $6.78 $32.42K SEC
Aug 19, 2025 Deborah C Jackson N/A Sale 4.53K $7.10 $32.17K SEC
Jul 01, 2025 Paul Francis Mcneice N/A Sale 331.00 $8.63 $2.86K SEC
Jul 01, 2025 Phyllis Gotlib N/A Sale 4.96K $8.63 $42.79K SEC
Jun 02, 2025 Paul Francis Mcneice N/A Sale 113.00 $6.61 $746.93 SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
RIMA MANAGEMENT, LLC 1.33M Jun 30, 2026 7.81% $0.36 16.94%
Morgan Stanley - Brokerage Accounts 1.28M Jun 30, 2026 7.52% $0.00 10.55%
Cable Car Capital LLC 1.00M Jun 30, 2026 5.89% $0.20 0.00%
Vanguard Capital Management, LLC 611.26K Jun 30, 2026 3.59% $0.00 7.75%
Acadian Asset Management LLC 494.44K Jun 30, 2026 2.91% $0.01 21.60%
BlackRock Inc 427.58K Jun 30, 2026 2.51% $0.00 9.25%
Renaissance Technologies Corp 263.22K Jun 30, 2026 1.55% $0.00 34.97%
Geode Capital Management, LLC 158.62K Jun 30, 2026 0.93% $0.00 -15.79%
Two Sigma Investments LLC 145.10K Jun 30, 2026 0.85% $0.00 9.09%
Jane Street Group LLC 141.28K Jun 30, 2026 0.83% $0.00 161.09%
Rock Point Advisors, LLC 134.36K Jun 30, 2026 0.79% $0.30 -1.27%
Dimensional Fund Advisors, Inc. 122.50K Jun 30, 2026 0.72% $0.00 37.65%
Marshall Wace Asset Management Ltd 108.06K Jun 30, 2026 0.64% $0.00 145.33%
Vanguard Fiduciary Trust Co 91.26K Jun 30, 2026 0.54% $0.00 14.18%
The Goldman Sachs Group Inc 81.73K Jun 30, 2026 0.48% $0.00 -33.87%
State Street Corp 56.60K Jun 30, 2026 0.33% $0.00 0.00%
Lotus Technology Management, LP 50.00K Jun 30, 2026 0.29% $0.56 0.00%
UBS Group AG 48.52K Jun 30, 2026 0.29% $0.00 934.48%
Bridgeway Capital Management, LLC 47.99K Jun 30, 2026 0.28% $0.01 0.00%
HSBC Holdings PLC 46.57K Jun 30, 2026 0.27% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 427.29K 2.51% ▲ 0.00% Sep 30, 2026
2 Russell Inv US Small Cap Equity Y 69.55K 0.41% ▲ 0.00% Sep 30, 2026
3 BSF Systematic US Eq Abs Ret A2 USD 58.13K 0.34% ▲ 0.00% Dec 31, 2025
4 Fidelity Extended Market Index 51.62K 0.30% ▼ 20.48% Aug 31, 2026
5 Dimensional US Small Cap ETF 48.87K 0.29% ▲ 0.00% Sep 30, 2026
6 iShares Micro-Cap ETF 44.25K 0.26% ▼ 0.68% Sep 30, 2026
7 Bridgeway Ultra-Small Company 42.99K 0.25% ▲ 0.00% Jun 30, 2026
8 Dunham Small Cap Value N 29.38K 0.17% ▲ 0.00% Aug 31, 2026
9 Fidelity Total Market Index 28.66K 0.17% ▲ 0.00% Aug 31, 2026
10 SEI Small Cap II A (SIIT) 26.00K 0.15% ▼ 7.80% Sep 30, 2026

Financial Highlights

▼
Market Cap: $254.79M
EBITDA: $-39.89M
Book Value: $13.07
Earnings/Share: $-4.77
Profit Margin: -35.75%
Operating Margin: -19.59%
ROA (TTM): -12.65%
ROE (TTM): -29.12%
Revenue (TTM): $218.52M
Revenue/Share (TTM): $13.25
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): -26.60%

Valuation Metrics

Enterprise Value: $47.20M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 15.36M
Shares Float: 11.94M
% Insiders: 4.57%
% Institutions: 47.52%
Shares Short: 206.59K
Shares Short (Prior Month): 160.46K
Short Ratio: 2.23
Short % Float: 1.40%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$249.33M
Cost of Goods Sold
adjust
$-116.47M
Gross Profit
subtotal
$132.86M
SG&A
adjust
$-88.05M
R&D
adjust
$-72.86M
Other Operating Expense
adjust
$-77.23M
Operating Income
subtotal
$-105.27M
Other / Non-Operating Items
adjust
$9.57M
Net Income
subtotal
$-95.70M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about AMWL.US!